AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Aug 7, 2012
30071_dirs_2012-08-07_0c44b610-0247-4836-8e16-e4e06447712c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-03
Reporting Person: Douglas Robert Andrew (COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-03 | ResMed Common Stock | M | 23333 | $23.095 | Acquired | 81023.637 | Direct |
| 2012-08-03 | ResMed Common Stock | S | 23333 | $34.640 | Disposed | 57690.637 | Direct |
| 2012-08-03 | ResMed Common Stock | M | 23334 | $23.095 | Acquired | 81024 | Direct |
| 2012-08-03 | ResMed Common Stock | S | 23334 | $35.00 | Disposed | 58223.9682 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-03 | ResMed Common Stock Options | $23.095 | M | 23333 | Disposed | 2013-11-10 | ResMed Common Stock (23333) | Direct |
| 2012-08-03 | ResMed Common Stock Options | $23.095 | M | 23334 | Disposed | 2013-11-10 | ResMed Common Stock (23334) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually.
F2: Transaction executed pursuant to 10b5-1.
F3: Includes 533.3312 shares purchased on April 30, 2012, pursuant to the company ESPP.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29